Top Premarket Gainers

MT Newswires Live10-14

Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment candidate for metabolic dysfunction-associated steatohepatitis.

Expion360 (XPON) stock was 57% higher following a 3.9% gain in the previous session.

Longboard Pharmaceuticals (LBPH) shares were up 51% after the company said it agreed to be acquired by Lundbeck in a deal valued at $2.60 billion.

Jasper Therapeutics (JSPR) stock was 26% higher after the company reported that 14 of 15 patients enrolled in both dose cohorts of its phase 1b/2a trial of a treatment candidate for chronic inducible urticaria achieved a clinical response.

B. Riley Financial (RILY) shares were up nearly 23% after the company said it has agreed to sell its Great American Group unit to Oaktree in a deal valued at $386 million.

Price: 3.1300, Change: +1.24, Percent Change: +65.61

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment